VTRS FY2025 SEC EDGAR DEF 14A #5 of 168 in industry

Viatris Inc CEO pay ratio

The CEO earned $15.3M in FY2025 against median worker pay of $46,729 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-02
Industry
Chemicals & Pharmaceuticals
Industry rank
#5/168

Data updated August 2026

Subscribe to Viatris Inc CEO pay filing updates (RSS)

CEO-to-worker pay ratio
327:1
High (Scale: 0–1000:1)
CEO pay
$15.3M
Median worker
$46,729

Answer first

Viatris Inc's FY2025 CEO total of $15.3M ranks #294 of 1,423 complete filings; its 327:1 pay ratio ranks #171. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $46,729. Industry placement uses the FY2025 SIC-28 peer cohort (# 5 of 168, 98th percentile - top 5% of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#294
$15.3M of 1,423 FY2025
Ratio rank
#171
327:1 of 1,423
Industry pct
98th
top 5% of industry peers by pay ratio

How Viatris Inc ranks nationally

Viatris Inc CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$15,280,383 Top 21% higher than 79% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). Below this entry. $15,000,000–$17,500,000: 88 companies (6%). This entry sits in this band. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Viatris Inc vs. Chemicals & Pharmaceuticals peers

CEO total pay ($15.3M) against pay ratio (327:1) for Viatris Inc (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both6459594.914379265.52229893630218606.638138277.126.5:1111.8:1197:1282.3:1367.5:1CEO total payPay ratio (CEO : median worker)Viatris Inc, CEO total pay: 15280383 · Pay ratio (CEO : median worker): 327:1Viatris IncPpg Industries Inc, CEO total pay: 16555264 · Pay ratio (CEO : median worker): 352:1Ppg Industries IncELI LILLY & Co, CEO total pay: 36698337 · Pay ratio (CEO : median worker): 293:1ELI LILLY & CoPfizer Inc, CEO total pay: 27585301 · Pay ratio (CEO : median worker): 277:1Pfizer IncHarrow, Inc., CEO total pay: 23606274 · Pay ratio (CEO : median worker): 263:1Harrow, Inc.Teva Pharmaceutical Industries Ltd, CEO total pay: 19168709 · Pay ratio (CEO : median worker): 257:1Teva Pharmaceutical Industries Ltd
Viatris Inc vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Viatris Inc's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Viatris Inc

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
327:1
FY2025
vs prior FY
+23:1
from FY2024 304:1
CEO $ YoY
+3.4%
$15.3M latest
Filings shown
5
FY2021–2025
Viatris Inc CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $14.7M - $36,865 398:1 -
2022 $14.8M +0.7% $34,858 424:1 +26:1
2023 $17.3M +17% $36,903 469:1 +45:1
2024 $14.8M -15% $48,598 304:1 -165:1
2025 $15.3M +3.4% $46,729 327:1 +23:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1792044, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
327:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$15.3M
Companies in Industry
168
vs. Industry Median
Above
#5 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Viatris Inc: HIGH · PEAK pay ratio

Viatris Inc's FY2025 ratio 327:1 ranks #5 of 168 Chemicals & Pharmaceuticals filers (98th percentile). the CEO earned 327× the median employee ($46,729) in FY2025.

Median employee $46,729 (PAR-MED); HIGH · PEAK stamps put about 327 median-wage years per CEO year.

CEO Total Pay

$15.3M

FY2025 Summary Compensation, above median

Pay Ratio

327:1

Elevated vs. peers

Viatris Inc in the higher Chemicals & Pharmaceuticals third

Viatris Inc's FY2025 ratio 327:1 ranks #5 of 168 Chemicals & Pharmaceuticals filers (98th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Viatris Inc's $15.3M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #294 and ratio rank #171 split - treat 327:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$15.3M
Median Employee Pay
$46,729
Pay Ratio
327:1
Filing Date
2026-04-02

Company Info

Ticker
VTRS
CIK
1792044
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1792044, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Viatris Inc's FY2025 ratio 327:1 ranks #5 of 168 Chemicals & Pharmaceuticals filers (98th percentile).

Read with Viatris Inc

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps HIGH · PEAK · PAR-MED.

Toll Brothers, Inc. · PEAK

ABS(ceo_total_comp) peer at $15.3M (Δ $8K heavier vs Viatris Inc); MID · ELITE-MED vs this page's HIGH · PEAK · PAR-MED.
Corcept Therapeutics Inc · PEAK

ABS(ceo_total_comp) peer at $15.3M (Δ $23K heavier vs Viatris Inc); MODEST · ELITE-MED vs this page's HIGH · PEAK · PAR-MED.
Kimberly Clark Corp · PEAK

ABS(ceo_total_comp) peer at $15.3M (Δ $45K heavier vs Viatris Inc); STEEP · PAR-MED vs this page's HIGH · PEAK · PAR-MED.
Assurant, Inc. · PEAK

ABS(ceo_total_comp) peer at $15.2M (Δ $58K lighter vs Viatris Inc); STEEP · PAR-MED vs this page's HIGH · PEAK · PAR-MED.
Ppg Industries Inc (SIC 28 pole)

Ppg Industries Inc stamps HIGH · PEAK nearest in-SIC by ABS(pay_ratio) to Viatris Inc's HIGH filing.
National dual ranks · #294/#171

Viatris Inc's FY2025 package sits #294 by CEO dollars and #171 by ratio under PEAK · HIGH.
Comp structure · PEAK

Viatris Inc's PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Viatris Inc (CIK 1792044), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.